Rankings
▼
Calendar
DNA Q2 2025 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$418M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$50M
-11.7% YoY
Gross Profit
$35M
70.1% margin
Operating Income
-$66M
-132.1% margin
Net Income
-$60M
-121.6% margin
EPS (Diluted)
$-1.10
QoQ Revenue Growth
+2.7%
Cash Flow
Operating Cash Flow
-$40M
Free Cash Flow
-$40M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$618M
Stockholders' Equity
$613M
Cash & Equivalents
$204M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$50M
$56M
-11.7%
Gross Profit
$35M
$42M
-18.1%
Operating Income
-$66M
-$223M
+70.6%
Net Income
-$60M
-$217M
+72.2%
Revenue Segments
Service
$10M
100%
← FY 2025
All Quarters
Q3 2025 →